Skip to content

SINOPHARMA: what changed

BE 0641.889.877NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lensesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€3,218
2024 · -€11,629+€14,847
Equity
€12,765
2024 · €9,547+€3,218
Cash
€3,118
2024 · €17,025-€13,906
Balance sheet total
€70,146
2024 · €80,923-€10,777

Largest movements

2024 to 2025
Assets
  • Cash -€13,906

    down €13,906 (-81.7%), from €17,025 to €3,118

    mainly Trade debts (-€6,888) and Tax, wage and social debts (-€3,959)

  • Receivables within one year +€3,129

    up €3,129 (+6.4%), from €49,000 to €52,129

    of which Other amounts receivable: +€2,753

Equity and liabilities
  • Trade debts -€6,888

    down €6,888 (-29.3%), from €23,505 to €16,617

  • Tax, wage and social debts -€3,959

    down €3,959 (-29.4%), from €13,484 to €9,524

  • Profit (loss) carried forward +€3,218

    up €3,218 (+31.3%), from -€10,289 to -€7,071

  • Other debts -€3,148

    down €3,148 (-9.2%), from €34,388 to €31,240

Income statement
  • Gross operating margin +€17,463

    up €17,463, from -€5,226 to €12,237

  • Taxes +€2,632

    first reported in 2025, at €2,632

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€11,629
Gross operating margin +€17,463
Other operating charges -€41
Financial charges +€57
Taxes -€2,632
Result 2025 €3,218
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€13,906
Investment €0
Financing €0
Cash 2024 €17,025
Net result for the year +€3,218
Receivables within one year -€3,129
Trade debts -€6,888
Tax, wage and social debts -€3,959
Other debts -€3,148
Cash 2025 €3,118
brings cash intakes cash out
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €80,923 €70,146 -€10,777 -13.3%
Current assets 29/58 €80,923 €70,146 -€10,777 -13.3%
Stocks and contracts in progress 3 €14,898 €14,898 = 0.0%
Stocks 30/36 €14,898 €14,898 = 0.0%
Amounts receivable within one year 40/41 €49,000 €52,129 +€3,129 +6.4%
Trade receivables 40 €6,681 €7,058 +€376 +5.6%
Other amounts receivable 41 €42,319 €45,072 +€2,753 +6.5%
Cash at bank and in hand 54/58 €17,025 €3,118 -€13,906 -81.7%
Total equity and liabilities 10/49 €80,923 €70,146 -€10,777 -13.3%
Equity 10/15 €9,547 €12,765 +€3,218 +33.7%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,236 €1,236 = 0.0%
Non-distributable reserves 130/1 €1,236 €1,236 = 0.0%
Reserves not available under the articles 1311 €1,236 €1,236 = 0.0%
Profit (loss) carried forward 14 -€10,289 -€7,071 +€3,218 +31.3%
Amounts payable 17/49 €71,376 €57,381 -€13,995 -19.6%
Amounts payable within one year 42/48 €71,376 €57,381 -€13,995 -19.6%
Trade debts 44 €23,505 €16,617 -€6,888 -29.3%
Suppliers 440/4 €23,505 €16,617 -€6,888 -29.3%
Taxes, remuneration and social security 45 €13,484 €9,524 -€3,959 -29.4%
Taxes 450/3 €13,484 €9,524 -€3,959 -29.4%
Other amounts payable 47/48 €34,388 €31,240 -€3,148 -9.2%
Other operating charges 640/8 €553 €594 +€41 +7.5%
Gross operating margin 9900 -€5,226 €12,237 +€17,463
Operating profit (loss) 9901 -€5,779 €11,643 +€17,422
Financial charges 65/66B €5,850 €5,793 -€57 -1.0%
Recurring financial charges 65 €5,850 €5,793 -€57 -1.0%
Profit (loss) for the period before taxes 9903 -€11,629 €5,850 +€17,479
Income taxes 67/77 - €2,632 +€2,632
Profit (loss) for the period 9904 -€11,629 €3,218 +€14,847
Profit (loss) for the period to be appropriated 9905 -€11,629 €3,218 +€14,847

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€12,764 to €12,764

Midpoint €12,764 · adjusted equity only

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €12,765
Indication €12,764

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€12,765
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€12,765

Capitalised earnings

net result for the year (9904)
2025
€3,218
2024
-€11,629
2023
-€1,510
2022
€14,659
2021
€16,247
Average result
-€3,307
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.